212 abstracts found.



Results filter

The impact of COVID-19 on cancer patients in the UK

Year:

Session type:

Charlotte Ide1, Lars Murdock, Ewa Zotov
1Cancer Research UK

Prospective data of >7,000 hospitalised patients with Cancer and COVID-19 derived from the COVID-19 Clinical Information Network and ISARIC WHO Coronavirus Clinical Characterisation Consortium.

Year:

Session type:

Carlo Palmieri1, Lance Turtle, Tom Drake, Annemarie Docherty, Ewen Harrison, Bill Greenhalf, Peter Openshaw, Kenneth Baillie, Malcom Semple
1University of Liverpool

Breast Cancer Management Pathways during the COVID-19 pandemic. Outcomes from the UK ‘alert level 4’ phase of the B-MaP-C study.

Year:

Session type:

Baek Kim, Rajiv Dave1, Alona Courtney, Rachel O'Connell, Tim Rattay, Vicky P Taxiarchi, Jamie J Kirkham, Elizabeth Camacho, Patricia Fairbrother, Nisha Sharma, Christopher WJ Cartlidge, Kieran Horgan, Stuart A McIntosh, Daniel R Leff, Raghavan Vidya, Shelley Potter, Chris Holcombe, Ellen Copson, Charlotte E Coles, Ramsey I Cutress, Ashu Gandhi, Cliona Kirwan
1Manchester University NHS Foundation Trust

The Impact of COVID-19 on Wellbeing and Work Ability in the NHS Oncology Workforce: Initial results of the COVID-NOW Study

Year:

Session type:

Susana Banerjee1, Jonathan Lim, Eleanor Thorne, Konstantinos Kamposioras, Anna-Marie Stevens, Clare Shaw, Emma Foreman, Rachel Broadbent, Jennifer Cotton, Joanne Droney, Michael Flynn, James Stewart, Kylie Fitch, Laura Pope, Sara Lister, Claire Hardy
1The Royal Marsden NHS Foundation Trust

Embedding trials into clinical practice – Learning from the Covid -19 crisis

Year:

Session type:

Helen Winter1, Natalie Blencowe, Stephen Lang, Jeremy Bewley, Ben Gibbison, Jane Blazeby
1University of Bristol

Development of a model to predict hospital admission and severe outcome in cancer patients with COVID-19

Year:

Session type:

Rohan Shotton, Cong Zhou, Rebecca Lee, Ann Tivey, Talvinder Bhogal, Oskar Wysoki, Elena Dickens, Prerana Huddar, Hayley McKenzie, Hayley Boyce, Alec Maynard, Michael Rowe, Sam Khan, Leonie Eastlake, Angelos Angelakas, Mark Baxter, Ellen Copson, Laura Horsley, Anne Thomas, Caroline Wilson, Tim Cooksley, Andre Freitas, Carlo Palmieri, Caroline Dive, Anne Armstrong

Time for research: improving research capacity in the health service post COVID-19

Year:

Session type:

Tamsyn Eida1, Stephen Peckham1, Wenjng Zhang, Ferhana Hashem, Sarah Spencer, Sally Kendall, Jessica Newberry Le Vay, Oliver Buckley-Mellor, Jyotsna Vohra
1University of Kent

The impact of virtual triage in the Rapid Diagnostic Service (RDS) in response to COVID-19

Year:

Session type:

Sifan Zheng, Sabine Martin, Loay Rahman, Sunnyath Ali, Yassen Mukadam, Jan Sindhar, Daniel Wheeler, Geraint Jones, Lindsay Steward, Luigi De Michele, Saoirse Dolly

COVID-19: NATIONAL REAL-TIME MONITORING AND RISK MITIGATION FOR CANCER PATIENTS (UK Coronavirus Cancer Monitoring Project)

Year:

Session type:

Lennard Lee

Head and neck cancer surgery during the COVID-19 pandemic: an international, multicentre, observational cohort study (Authorship: COVIDSurg Collaborative)

Year:

Session type:

Richard Shaw1
1University of Liverpool

Questions and priorities cancer patients and their carers would like addressed from research into COVID-19

Year:

Session type:

Christian Mitchell1, Emma Kinloch, Lennard Lee
1University of Birmingham

C-CRES (COVID-19 and Cancer Research Engagement Study): UK pilot survey of patient concerns about participating in cancer research during COVID-19

Year:

Session type:

Louis Fox1, Harriet Wylie, Fee Cahill, Anna Haire, Saran Green, Joyce Kibaru, Catherine Hartley, Richard Sullivan, Mieke Van Hemelrijck
1Translational Oncology and Urology Research, King's College London

Cutaneous lymphoma patient experience of outpatient consultations during the COVID-19 pandemic

Year:

Session type:

Christina Hague1, Richard Cowan, Nina Farquharson, Timothy Illidge, Eileen Parry, Christine Tetlow, Joanne Woolley, Jane Gibson
1Christie NHS Foundation Trust

A novel use for routine CBCT imaging to detect COVID-19

Year:

Session type:

Abigael Clough1, Abigael Clough, Josephine Sanders, Kathryn Banfill, Corrine Faivre-Finn, Gareth Price, Cynthia Eccles, Marcel Van Herk, Marianne Aznar
1Christie NHS Foundation Trust

Changes in the management of patients having radical radiotherapy for lung cancer in the UK during the COVID-19 pandemic (COVID-RT Lung)

Year:

Session type:

Kathryn Banfill, Gareth Price, Kate Wicks, Dila Mokhtar, Keith Harland, Andrew Brocklehurst, William Croxford, Sheena Lam, Niki Panakis, Kamalram Thippu Jayaprakash, Matthew Hatton, Ceri Powell, Corinne Faivre-Finn

The impact of COVID-19 on surgical outcomes – a first report from the South East London (SEL) Cancer Surgery Hub

Year:

Session type:

Beth Russell, Harvey Dickinson, Graham Roberts, Charlotte Moss, Gincy George, Sophie Irwin, Jonathan Olsburgh, Jain Urvashi, Francesca Cocco, Sarah McCrindle, Aina Brunet, Ricard Simo, Parthi Srinivasan, Andreas Prachailias, Rujun Ma, Jenny Geh, Stephanie Fraser, Ella Doerge, Ben Challacombe, Marios Hadjipavlou, Rosaria Scarpinata, Paolo Sorelli, Saoirse Dolly, Mieke Van Hemelrijck, Kate Haire

Impact of COVID-19 on patients who received systemic anticancer treatment (SACT) during the COVID-19 outbreak; The Guy’s Cancer Centre experience

Year:

Session type:

Eirini Tsotra, Charalampos Gousis, Beth Russell, Charlotte Moss, Gincy George, Eleanor Jones, Pavetha Seeva, Aarani Devi, Jose Roca, Vasiliki Michalarea, Kamural Zaki, Ailsa Sita-Lumsden, Debra Josephs, Deborah Enting, Elinor Sawyer, Angela Swampillai, Mary Lei, Daniel Smith, Paul Ross, James Spicer, Sophie Papa, Anne Rigg, Ana Montes, Mieke Van Hemelrijck, Saoirse Dolly

Development and validation of a multivariable machine learning algorithm to predict risk of cancer in patients referred urgently from primary care

Year:

Session type:

Richard Savage, Mike Messenger, Richard Neal, Rosie Ferguson, Geoff Hall, Colin Johnston, Kat Lloyd, Matt Neal, Nigel Sansom, Nisha Sharma, Beth Shinkins, Jim Skinner, Giles Tully, Sean Duffy, Peter Selby

Deep Learning Auto-segmentation of Prostate Cancer from MRI data

Year:

Session type:

David Gillespie, Ian S. Boon, Connah Kendrick, Cheng S. Boon1, Moi Hoon Yap
1Clatterbridge Cancer Centre

Deep learning-based segmentation and quantification of temporalis muscle for sarcopenia assessment is an independent prognostic factor in glioblastoma

Year:

Session type:

Ella Mi, Radvile Mauricaite, Lillie Pakzad-Shahabi, Katherine Pike, Matthew Williams

Optimised radiation dose decisions using AI deep learning & reinforcement learning in small cell lung cancer.

Year:

Session type:

Deva Reddy1
1Care Oncology Clinic

Prostate  cancer detection using Artificial Intelligence in MRI

Year:

Session type:

Reddy Reddy, Dr.sanjai Addla, Dr.raghu Nath

Factors of age disparities in colon cancer survival in New Zealand

Year:

Session type:

Sophie Pilleron, Camille Maringe, Hadrien Charvat, June Atkinson, Eva Morris, Diana Sarfati

Cancer Incidence by Deprivation in England, 2013-2017

Year:

Session type:

Nick Payne, Katrina Brown, Christine Delon

Are there socio-economic inequalities in utilisation of predictive biomarker tests and biological and precision therapies for cancer? A systematic review and meta-analysis

Year:

Session type:

Ruth Norris, Rosie Dew, Linda Sharp, Alastair Greystoke, Stephen Rice, Kristina Johnell, Adam Todd

The association between rurality, deprivation and time to help-seeking for cancer symptoms: a secondary analysis of cross-sectional survey data

Year:

Session type:

Georgie St Pier, Kate Brain, Grace McCutchan, Giles Greene

The Awareness and Beliefs About Cancer (ABACus)trial of a targeted cancer awareness intervention

Year:

Session type:

Kate Brain1, Yvonne Moriarty, Mandy Lau, Bernadette Sewell, Rob Trubey, Harriet Quinn-Scoggins, Sioned Owen, Louise Padgett, Vasiliki Kolovou, Julie Hepburn, Peter Buckle, Rebecca Playle, Julia Townson, Michael Robling, Stephanie Gilbert, Polyxeni Dimitropoulou, Adrian Edwards, Caroline Mitchell, Maura Matthews, Stephanie Smits, Fiona Wood, Richard Neal
1Cardiff University

The oldest-old (>80 years) are at risk of poorer quality of life and health status up to five years following colorectal cancer treatment: Findings from the ColoREctal Wellbeing (CREW) cohort study

Year:

Session type:

Amanda Cummings, Rebecca Foster, Lynn Calman, Natalia Permyakova, Jackie Bridges, Theresa Wiseman, Teresa Corbett, Peter Smith, Claire Foster

The impact of ethnicity on breast cancer surgery decisions and mortality in England: a population-based cohort study

Year:

Session type:

Radhika Gulati, Bernard Rachet

NeuroSAFE PROOF feasibility study – improving erectile function recovery for men undergoing radical prostatectomy for localised prostate cancer

Year:

Session type:

Eoin Dinneen, Jack Grierson, Aiman Haider, Alex Freeman, Jon Oxley, Tim Briggs, Senthil Nathan, Norman Williams, Chris Brew-Graves, Raj Persad, Jon Aning, Charlie Jamieson, Marzena Ratynska, Imen Ben-Salha, Rhys Ball, Rosie Clow, Clare Allen, Dan Heffernan-Ho, John Kelly, Greg Shaw

An evaluation of a therapeutic radiographer led Sexual Care after Radiotherapy clinic

Year:

Session type:

Heather Nisbet, Loryn Caulfield

Sexual Wellbeing after Colorectal Cancer Treatment: Results from the Colorectal Wellbeing Study

Year:

Session type:

Jane Frankland1, Sally Wheelwright, Natalia Permyakova, David Wright, Nicole Collaco, Peter Smith, Lynn Calman, Jane Winter, Alison Richardson, Claire Foster
1University of Southampton

Immune responses in pancreatic cancer may be restricted by prevalence of activated regulatory T-cells, dysfunctional and senescent T-cells

Year:

Session type:

Shivan Sivakumar1, Enas Abu-Shah, David Ahern, Edward Arbe-Barnes, Nagina Mangal, Srikanth Reddy, Aniko Rendek, Alistair Easton, Elke Kurz, Michael Silva, Zahir Soonawalla, Lara Heij, Rachael Bashford-Rogers, Mark Middleton, Michael Dustin
1University of Oxford

RAS orchestrates the increase of interstitial adenosine in lung adenocarcinoma to promote immune evasion

Year:

Session type:

Sophie de Carné Trécesson, Jesse Boumelha, Chris Moore, Deborah Caswell, Mariana Silva dos Santos, James MacRae, Edurne Mugarza-Strobl, Miriam Molina-Arcas, Paul Smith, Kris Sachsenmeier, Charles Swanton, Philip East, Julian Downward

Radiation and DMXAA limit tumour development in a urethane-induced lung cancer model through inflammatory response

Year:

Session type:

Kay Shigemori, Yanyan Jiang, Stephen Stribbling, Jennifer C. Martin, Luiza H.M. Lourenco, Anderson J. Ryan

CD4 and CD8 T-cells contribute to the efficacy of the T-cell redirecting antibody CEA-TCB and TGFβ dampens its activity in in vitro colorectal cancer models

Year:

Session type:

Maria Semiannikova, Alice Newey, Fredrik Wallberg, Marina Bacac, Alan Melcher, Naureen Starling, David Cunningham, Ben Challoner, Andrew Woolston, Louise Barber, Marco Gerlinger

Deconvolution of global gene expression profiles identifies differentially expressed immune-related gene profiles on aromatase inhibitor-resistant estrogen receptor positive tumours

Year:

Session type:

Milana Bergamino Sirvén1, Gabriele Morani, Joel Parker, Gene Schuster, Elena López-Knowles, Judith Bliss, Mitch Dowsett, Maggie Cheang
1Institute of Cancer Research (ICR)

Eosinophils are critical for response to immune checkpoint blockade in breast cancer and other cancer types

Year:

Session type:

Hannah Garner, Olga Blomberg, Lorenzo Spagnuolo, Leonie Voorwerk, Ewald van Dyk, Myriam Chalabi, Olga Isaeva, Noor Bakker, Kelly Kersten, Chris Klaver, Maxime Duijst, Dorien Pastoors, Cheei-Sing Hau, Kim Vrijland, Elisabeth Raeven, Louisa Hoes, Willemijn Theelen, Paul Baas, Emile Voest, Lodewyk Wessels, Karin de Visser, Marleen Kok

Retrospective review of the efficacy and tolerability of neoadjuvant biosimilar Trastuzumab (Herzuma) in combination with Pertuzumab and chemotherapy in HER2-positive early breast cancer.

Year:

Session type:

Ciara Martin1, Nadia Searle, Caroline Wilson, Alice Shaw
1University of Sheffield

Atezolizumab and Pembrolizumab Immunotherapy in the treatment of metastatic urothelial cancers – real world experience in Devon and Cornwall.

Year:

Session type:

Hannah Bond, Frances Mark, Rachel Wilkinson, Jennifer Hanks, Peter Sankey, Anna Lydon, Denise Sheehan, John Mcgrane

Clinical correlates of peripheral T cell immune awakening

Year:

Session type:

Zena Salih, Sara Valpione, Antonia Banyard, Joshua Tweedy, Elena Galvani, Philippa Middlehurst, Sarah Mills, John Weightman, Avinash Gupta, Paul Lorigan, Nathalie Dhomen, Richard Marais

Outcomes for Advanced Non-Small Cell Lung Cancer Patients Treated with First-line Palliative Chemoimmunotherapy

Year:

Session type:

Elinor Gatfield1, Sini Shah, Carrie Morgan, Elspeth Saunders, Sunil Skaria, Dakshinamoorthy Muthukumar
1Addenbrooke's Hospital

Measuring DNA damage in blood cells as a less-invasive diagnostic tool for oesophageal adenocarcinoma

Year:

Session type:

Rachel Lawrence, Hasan Haboubi, Lucy Swithenbank, Lisa Williams, Shareen Doak, Gareth Jenkins

Calibration and validation of the LLP lung cancer risk stratification model

Year:

Session type:

Daniel Vulkan, John Field, Michael Davies, Stephen Duffy, Rhian Gabe

Patient outcomes following referral to a regional Cancer of Unknown Primary (CUP) team – a 1000 patient study

Year:

Session type:

Karin Purshouse1, Mark Stares1, Gillian Knowles, Rachel Haigh, Jenny Irvine, Rebekah Patton, Jo McGinty, Barry Laird, Alan Christie, Marjory MacLennan, Colin Barrie, Sally Clive
1University of Edinburgh

A volunteer lifestyle coach programme can support weight management in women attending routine breast screening clinics  – the ActWELL study

Year:

Session type:

Annie Anderson1, Angela Craigie, Peter T Donnan, Stephanie Gallant, Amy Hickman, Chloe McAdam, Jennifer McKell, Paul McNamee, E. Jane Macaskill, Nanette Mutrie, Ronan E O'Carroll, Petra Rauchhaus, Naveed Sattar, Martine Stead, Shaun Treweek
1University of Dundee

Can an educational video improve the adequacy of bowel preparation for patients undergoing their first colonoscopy? The EBOPS study

Year:

Session type:

Thomas Archer1, Mo Thoufeeq, Bernard Corfe, Stuart Riley, Andrew Baxter, Waleed Fateen
1Sheffield Teaching Hospitals NHS Foundation Trust

What is the sensitivity of CXR for lung cancer? & Are outcomes different for patients who have a ‘true’ positive’ compared to those who have a ‘false negative’ CXR?

Year:

Session type:

Stephen Bradley, Richard Neal, Martyn PT Kennedy, Matthew EJ Callister, Luke NF Hatton, Bethany Shinkins, Luke TA Mounce, William T Hamilton

The Fraction of Cancer Attributable to Smoking by Deprivation in England, 2013-2017

Year:

Session type:

Nick Payne, Katrina Brown

Delivering smoking cessation treatment at lung screening services: views of screening eligible current and recent ex-smokers.

Year:

Session type:

Samantha Groves, David Baldwin, Kate Brain, Philip Crosbie, John Field, Grace McCutchan, Rachael Murray, Jamie Ostroff, Samantha Quaife, Janelle Yorke, Lorna McWilliams